Cash flow Viyash Scientific Limited

Equities

VIYASH

INE807F01027

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:49 2026-03-13 am EDT			5-day change	1st Jan Change
195.75 ^INR	0.00%		-3.57%	-5.96%

Feb. 13	Ruchira Papers Limited Announces Board and Committee Changes, Effective January 23 2026	CI
Feb. 06	Viyash Scientific Limited, Q3 2026 Earnings Call, Feb 06, 2026

2eaea7.Zb-EgZS5LewJFFS4zpuGetF5Y7vjJla6trtkFficxo0.XfGxtt3PT59lIgXo-c3EEZk3COvXXiXWg94LZKnzqcM1-tHW1tNv3D1LHQ

Published financial data: VIYASH SCIENTIFIC LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	13.62B	14.13B	14.21B	13.7B	15.51B
Total Revenues	13.62B	14.13B	14.21B	13.7B	15.51B
Cost of Goods Sold, Total	7.17B	8.15B	8.58B	7.85B	8.38B
Gross Profit	6.45B	5.98B	5.63B	5.84B	7.14B
Selling General & Admin Expenses, Total	1.88B	2.33B	2.62B	2.55B	2.9B
Provision for Bad Debts	30.31M	3.26M	1.83M	620K	120K
Depreciation & Amortization - (IS)	506M	511M	557M	615M	665M
Other Operating Expenses	2.34B	2.55B	2.6B	2.45B	2.57B
Other Operating Expenses, Total	4.76B	5.4B	5.78B	5.61B	6.13B
Operating Income	1.69B	584M	-153M	233M	1.01B
Interest Expense, Total	-193M	-135M	-297M	-464M	-560M
Interest And Investment Income	16.21M	4.07M	12.1M	6.7M	27.24M
Net Interest Expenses	-176M	-131M	-285M	-458M	-532M
Currency Exchange Gains (Loss)	-42.16M	63.03M	-114M	-153M	-80.49M
Other Non Operating Income (Expenses)	-16.64M	15.52M	-27.11M	29.97M	9.99M
EBT, Excl. Unusual Items	1.45B	532M	-580M	-348M	405M
Restructuring Charges	-38.26M	-	-412M	-228M	35.8M
Merger & Related Restructuring Charges	-	-	-9.9M	-	-52.61M
Impairment of Goodwill	-	-	-204M	-	-
Gain (Loss) On Sale Of Investments	25.79M	3.18M	510K	170K	1.49M
Gain (Loss) On Sale Of Assets	6.98M	-690K	20.42M	55.42M	60.18M
Asset Writedown	-30.69M	-340K	-1.61M	-1.64M	-2.75M
Insurance Settlements	-	-	-	84.26M	7.05M
Other Unusual Items	-49.97M	-	-190M	-108M	-10.68M
EBT, Incl. Unusual Items	1.37B	534M	-1.38B	-546M	443M
Income Tax Expense	322M	83.26M	-157M	-250M	120M
Earnings From Continuing Operations	1.04B	451M	-1.22B	-296M	323M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	1.04B	451M	-1.22B	-296M	323M
Minority Interest	-90.1M	-38.09M	8.18M	-62.56M	-104M
Net Income - (IS)	954M	413M	-1.21B	-359M	219M
Net Income to Common Incl Extra Items	954M	413M	-1.21B	-359M	219M
Net Income to Common Excl. Extra Items	954M	413M	-1.21B	-359M	219M
Per Share Items
Net EPS - Basic	3.87	1.67	-4.88	-1.44	0.88
Basic EPS - Continuing Operations	3.87	1.67	-4.88	-1.44	0.88
Basic Weighted Average Shares Outstanding	247M	247M	248M	249M	249M
Net EPS - Diluted	3.85	1.65	-4.88	-1.44	0.85
Diluted EPS - Continuing Operations	3.85	1.65	-4.88	-1.44	0.85
Diluted Weighted Average Shares Outstanding	248M	251M	248M	249M	256M
Normalized Basic EPS	3.31	1.19	-1.43	-1.13	0.6
Normalized Diluted EPS	3.3	1.17	-1.43	-1.13	0.58
Dividend Per Share	0.5	-	-	-	-
Payout Ratio	-	29.92	-	-	-
Supplemental Items
EBITDA	2.09B	988M	312M	768M	1.58B
EBITA	1.75B	619M	-70.25M	320M	1.1B
EBIT	1.69B	584M	-153M	233M	1.01B
EBITDAR	2.1B	1.01B	346M	810M	1.67B
Total Revenues (As Reported)	13.7B	14.24B	14.27B	13.81B	15.66B
Effective Tax Rate - (Ratio)	23.55	15.6	11.39	45.81	27.19
Total Current Taxes	350M	137M	75.15M	139M	407M
Total Deferred Taxes	-28.6M	-53.72M	-232M	-390M	-287M
Normalized Net Income	818M	294M	-354M	-280M	149M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	30.89M	27.58M	24.49M	23.07M	31.36M
Non-Cash Pension Expense	4.61M	5.65M	6.56M	5.67M	8.93M
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	10.41M	19.94M	34.04M	42.46M	86.33M
Imputed Operating Lease Interest Expense	4.71M	6.71M	20.02M	33.86M	79.77M
Imputed Operating Lease Depreciation	5.7M	13.23M	14.02M	8.6M	6.56M
Maintenance & Repair Expenses, Total	219M	219M	243M	255M	257M
Stock-Based Comp., SG&A Exp. (Total)	72.34M	333M	354M	222M	324M
Stock-Based Comp., Other (Total)	60.69M	-	-	-	-
Total Stock-Based Compensation	133M	333M	354M	222M	324M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	537M	575M	416M	648M	627M
Short Term Investments	650K	1.38M	460K	1.12M	4.18M
Trading Asset Securities, Total	55.9M	12.99M	-	25.01M	-
Total Cash And Short Term Investments	594M	589M	416M	674M	631M
Accounts Receivable, Total	3.46B	3.29B	3.41B	3.36B	3.63B
Other Receivables	102M	7.07M	4.42M	16.92M	10.74M
Notes Receivable	1.9M	2.52M	3.35M	1.41M	2.12M
Total Receivables	3.57B	3.3B	3.42B	3.37B	3.64B
Inventory	2.64B	3.48B	3.46B	3.46B	3.85B
Prepaid Expenses	56.42M	59.1M	61.69M	66.96M	69.74M
Other Current Assets, Total	276M	437M	543M	650M	539M
Total Current Assets	7.14B	7.87B	7.9B	8.23B	8.74B
Gross Property Plant And Equipment	5.08B	5.22B	6.03B	5.84B	6.11B
Accumulated Depreciation	-1.6B	-1.96B	-2.51B	-2.73B	-3.12B
Net Property Plant And Equipment	3.48B	3.25B	3.52B	3.11B	2.99B
Long-term Investments	769M	368M	50K	50K	50K
Goodwill	1.74B	1.85B	2.4B	2.35B	2.49B
Other Intangibles, Total	444M	559M	684M	617M	534M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	205M	292M	454M	784M	1.03B
Other Long-Term Assets, Total	151M	222M	333M	313M	238M
Total Assets	13.93B	14.41B	15.29B	15.4B	16.02B
Liabilities
Accounts Payable, Total	2.3B	2.58B	2.44B	2.6B	2.57B
Accrued Expenses, Total	54.12M	72.08M	60M	80.7M	139M
Short-term Borrowings	1.03B	1.6B	1.82B	2.46B	1.61B
Current Portion of Long-Term Debt	272M	329M	330M	627M	116M
Current Portion of Leases	68.9M	81.57M	87.27M	73.17M	85.6M
Current Income Taxes Payable	227M	82.34M	63.41M	33.43M	119M
Unearned Revenue Current, Total	-	-	-	101M	-
Other Current Liabilities	663M	380M	456M	294M	415M
Total Current Liabilities	4.61B	5.12B	5.26B	6.27B	5.05B
Long-Term Debt	937M	1.22B	1.83B	1.43B	2.74B
Long-Term Leases	454M	419M	370M	291M	263M
Pension & Other Post Retirement Benefits	64.39M	56.89M	74.68M	65.45M	80.43M
Deferred Tax Liability Non Current	69.3M	59.85M	123M	68.73M	37.4M
Other Non Current Liabilities	28.67M	130M	144M	152M	146M
Total Liabilities	6.16B	7.01B	7.8B	8.27B	8.32B
Common Stock, Total	497M	497M	499M	499M	501M
Additional Paid In Capital	8.73B	8.74B	9B	9B	9.2B
Retained Earnings	827M	1.12B	1.23B	1.2B	1.5B
Treasury Stock	-89.43M	-57.71M	-57.71M	-24.72M	-24.72M
Comprehensive Income and Other	-2.69B	-3.38B	-3.69B	-4.11B	-4.13B
Total Common Equity	7.28B	6.92B	6.99B	6.57B	7.04B
Minority Interest	487M	480M	504M	564M	659M
Total Equity	7.76B	7.4B	7.49B	7.13B	7.7B
Total Liabilities And Equity	13.93B	14.41B	15.29B	15.4B	16.02B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	247M	247M	248M	249M	250M
ECS Total Common Shares Outstanding	247M	247M	248M	249M	250M
Book Value / Share	29.47	27.99	28.12	26.37	28.19
Tangible Book Value	5.09B	4.51B	3.9B	3.6B	4.02B
Tangible Book Value Per Share	20.62	18.24	15.71	14.45	16.1
Total Debt	2.76B	3.65B	4.44B	4.88B	4.81B
Net Debt	2.17B	3.06B	4.02B	4.2B	4.18B
Debt Equivalent of Unfunded Proj. Benefit Obligation	69.71M	76.97M	99.38M	97.49M	104M
Debt Equivalent Oper. Leases	83.28M	160M	272M	340M	691M
Minority Interest, Total (Incl. Fin. Div)	487M	480M	504M	564M	659M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	917M	1.29B	1.32B	1.13B	1.37B
Inventories - Work In Process, Total	415M	568M	489M	534M	600M
Inventories - Finished Goods, Total	1.31B	1.62B	1.65B	1.79B	1.87B
Inventories - Others	3.76M	4.97M	5.23M	5.54M	5.84M
Land - (BS)	89.43M	85.14M	94.77M	92.1M	84.91M
Buildings, Total	1.07B	1.09B	1.23B	1.31B	1.32B
Machinery, Total	2.48B	2.79B	3.26B	3.51B	3.67B
Full Time Employees	1.77K	1.77K	1.3K	1.2K	1.24K
Accumulated Allowance for Doubtful Accounts (Supple)	54.99M	38.36M	30.07M	33.48M	37.57M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	954M	413M	-1.21B	-359M	219M
Depreciation & Amortization - CF	408M	441M	452M	510M	547M
Amortization of Goodwill and Intangible Assets - (CF)	67.2M	35.17M	83.21M	87.67M	96.19M
Depreciation & Amortization, Total	475M	477M	535M	598M	643M
Amortization of Deferred Charges, Total - (CF)	30.94M	34.28M	21.76M	17.9M	21.79M
(Gain) Loss From Sale Of Asset	-6.98M	690K	-20.42M	-55.42M	-60.18M
(Gain) Loss on Sale of Investments - (CF)	-25.96M	-3.18M	-510K	-400K	-1.49M
Asset Writedown & Restructuring Costs	30.69M	340K	618M	1.64M	2.8M
Provision for Credit Losses	-	1.16M	120K	-	-
Stock-Based Compensation (CF)	72.34M	333M	354M	222M	324M
Provision and Write-off of Bad Debts	8.99M	3.11M	9.39M	14.39M	-1.15M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	317M	-59.57M	379M	323M	570M
Change In Accounts Receivable	-395M	-407M	-413M	-87.82M	-479M
Change In Inventories	-456M	-1.15B	50.79M	2.86M	-469M
Change In Accounts Payable	89.29M	655M	-170M	-371M	64.25M
Change in Other Net Operating Assets	52.77M	6.95M	15.85M	-400K	-100K
Cash from Operations	1.15B	306M	168M	306M	834M
Capital Expenditure	-528M	-325M	-862M	-308M	-391M
Sale of Property, Plant, and Equipment	82.6M	11.91M	117M	192M	97M
Cash Acquisitions	-1.4B	-685M	-154M	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	1.93B	37.48M	238M	-82.23M	35.27M
Other Investing Activities, Total	16.24M	4.26M	12.34M	79.73M	10.82M
Cash from Investing	96.48M	-956M	-650M	-119M	-248M
Short Term Debt Issued, Total	-	549M	558M	584M	-
Long-Term Debt Issued, Total	879M	675M	575M	548M	2.68B
Total Debt Issued	879M	1.22B	1.13B	1.13B	2.68B
Short Term Debt Repaid, Total	-435M	-	-	-	-829M
Long-Term Debt Repaid, Total	-1.69B	-362M	-452M	-693M	-2B
Total Debt Repaid	-2.13B	-362M	-452M	-693M	-2.83B
Issuance of Common Stock	104M	21.16M	-	59.85M	74.46M
Common Dividends Paid	-	-123M	-	-	-
Common & Preferred Stock Dividends Paid	-	-123M	-	-	-
Other Financing Activities, Total	-242M	-87.51M	-359M	-454M	-531M
Cash from Financing	-1.39B	673M	322M	45.46M	-607M
Foreign Exchange Rate Adjustments	-	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	14.66M	-	-	-
Net Change in Cash	-144M	37.52M	-159M	232M	-21.5M
Supplemental Items
Cash Interest Paid	228M	162M	356M	453M	513M
Cash Income Tax Paid (Refund)	438M	268M	146M	141M	276M
Levered Free Cash Flow	761M	-42M	-565M	402M	454M
Unlevered Free Cash Flow	881M	42.43M	-380M	692M	803M
Change In Net Working Capital	284M	842M	333M	-17.05M	424M
Net Debt Issued / Repaid	-1.25B	862M	681M	440M	-151M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.39	2.58	-0.64	0.95	4.01
Return on Total Capital	9.64	3.38	-0.83	1.22	5.14
Return On Equity %	13.85	5.94	-16.38	-4.05	4.35
Return on Common Equity	13.49	5.81	-17.42	-5.29	3.21
Margin Analysis
Gross Profit Margin %	47.38	42.32	39.61	42.67	46.02
SG&A Margin	13.83	16.52	18.42	18.6	18.68
EBITDA Margin %	15.36	6.99	2.19	5.61	10.2
EBITA Margin %	12.89	4.38	-0.49	2.34	7.11
EBIT Margin %	12.39	4.13	-1.08	1.7	6.49
Income From Continuing Operations Margin %	7.67	3.19	-8.58	-2.16	2.08
Net Income Margin %	7.01	2.92	-8.53	-2.62	1.41
Net Avail. For Common Margin %	7.01	2.92	-8.53	-2.62	1.41
Normalized Net Income Margin	6.01	2.08	-2.49	-2.05	0.96
Levered Free Cash Flow Margin	5.59	-0.3	-3.98	2.93	2.92
Unlevered Free Cash Flow Margin	6.47	0.3	-2.67	5.05	5.18
Asset Turnover
Asset Turnover	0.95	1	0.95	0.89	0.99
Fixed Assets Turnover	3.87	4.2	4.19	4.13	5.08
Receivables Turnover (Average Receivables)	4.1	4.18	4.24	4.05	4.44
Inventory Turnover (Average Inventory)	2.96	2.66	2.47	2.27	2.29
Short Term Liquidity
Current Ratio	1.55	1.54	1.5	1.31	1.73
Quick Ratio	0.9	0.76	0.73	0.65	0.85
Operating Cash Flow to Current Liabilities	0.25	0.06	0.03	0.05	0.17
Days Sales Outstanding (Average Receivables)	89.12	87.24	86.08	90.39	82.2
Days Outstanding Inventory (Average Inventory)	123.22	137.14	147.61	161.34	159.41
Average Days Payable Outstanding	107.84	98.5	107.08	117.57	105.75
Cash Conversion Cycle (Average Days)	104.5	125.88	126.61	134.16	135.87
Long Term Solvency
Total Debt/Equity	35.56	49.28	59.21	68.4	62.47
Total Debt / Total Capital	26.23	33.01	37.19	40.62	38.45
LT Debt/Equity	17.92	22.19	29.33	24.1	38.97
Long-Term Debt / Total Capital	13.22	14.87	18.42	14.31	23.98
Total Liabilities / Total Assets	44.25	48.64	51.01	53.72	51.91
EBIT / Interest Expense	8.76	4.32	-0.52	0.5	1.8
EBITDA / Interest Expense	11.23	7.85	1.28	1.79	2.95
(EBITDA - Capex) / Interest Expense	8.49	5.45	-1.62	1.12	2.25
Total Debt / EBITDA	1.28	3.44	11.62	5.87	2.92
Net Debt / EBITDA	1	2.88	10.53	5.06	2.53
Total Debt / (EBITDA - Capex)	1.69	4.96	-9.24	9.34	3.82
Net Debt / (EBITDA - Capex)	1.33	4.16	-8.37	8.05	3.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	15.46	3.76	0.57	-3.6	13.26
Gross Profit, 1 Yr. Growth %	15.9	-7.31	-5.88	3.85	22.14
EBITDA, 1 Yr. Growth %	25.96	-52.79	-68.31	146.45	106.07
EBITA, 1 Yr. Growth %	30.79	-64.7	-111.43	-556.09	244.44
EBIT, 1 Yr. Growth %	34.76	-65.38	-126.48	-251.66	332.86
Earnings From Cont. Operations, 1 Yr. Growth %	27.31	-56.86	-372.49	-75.72	-208.94
Net Income, 1 Yr. Growth %	36.53	-56.78	-395.83	-70.4	-160.99
Normalized Net Income, 1 Yr. Growth %	76.3	-64.02	-221.63	-20.92	-153.18
Diluted EPS Before Extra, 1 Yr. Growth %	35.09	-57.14	-399.39	-70.44	-158.92
Accounts Receivable, 1 Yr. Growth %	8.59	-4.88	3.56	-1.56	8.2
Inventory, 1 Yr. Growth %	20.48	31.63	-0.54	0.04	11.29
Net Property, Plant and Equip., 1 Yr. Growth %	-2.28	-6.47	7.93	-11.62	-3.79
Total Assets, 1 Yr. Growth %	-4.79	3.51	5.39	0.74	4
Tangible Book Value, 1 Yr. Growth %	12.35	-11.38	-11.75	-7.79	11.76
Common Equity, 1 Yr. Growth %	5.9	-4.84	0.97	-6.04	7.3
Cash From Operations, 1 Yr. Growth %	-0.5	-73.34	-45.06	82.03	172.47
Capital Expenditures, 1 Yr. Growth %	29.73	-38.55	165.46	-64.25	26.88
Levered Free Cash Flow, 1 Yr. Growth %	62.49	-105.65	11.03K	-171.09	12.88
Unlevered Free Cash Flow, 1 Yr. Growth %	31	-95.08	-578.53	-282.27	16.09
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.46	9.46	2.15	-1.54	4.49
Gross Profit, 2 Yr. CAGR %	15.86	3.65	-6.6	-1.13	12.62
EBITDA, 2 Yr. CAGR %	26.91	-22.89	-61.41	-11.62	125.36
EBITA, 2 Yr. CAGR %	32.95	-32.06	-79.99	-27.81	296.35
EBIT, 2 Yr. CAGR %	36.36	-31.7	-69.84	-36.63	156.21
Earnings From Cont. Operations, 2 Yr. CAGR %	35.52	-25.89	8.06	-18.67	-48.57
Net Income, 2 Yr. CAGR %	40.05	-23.18	12.67	-6.42	-57.51
Normalized Net Income, 2 Yr. CAGR %	73.82	-20.35	-34.17	-1.93	-35.15
Diluted EPS Before Extra, 2 Yr. CAGR %	39.09	-23.91	12.58	-5.92	-58.27
Accounts Receivable, 2 Yr. CAGR %	11.53	1.63	-0.75	0.97	3.2
Inventory, 2 Yr. CAGR %	14.94	25.93	14.42	-0.25	5.52
Net Property, Plant and Equip., 2 Yr. CAGR %	19.34	-4.4	0.61	-2.33	-7.79
Total Assets, 2 Yr. CAGR %	0.17	-0.73	4.79	3.04	2.35
Tangible Book Value, 2 Yr. CAGR %	8.78	-0.21	-12.44	-9.79	1.52
Common Equity, 2 Yr. CAGR %	1.47	0.39	-2	-2.6	0.41
Cash From Operations, 2 Yr. CAGR %	-0.55	-48.49	-61.73	0	122.7
Capital Expenditures, 2 Yr. CAGR %	44.09	-10.71	27.72	-2.59	-32.65
Levered Free Cash Flow, 2 Yr. CAGR %	51.01	-70.05	-12.74	789.65	-10.42
Unlevered Free Cash Flow, 2 Yr. CAGR %	31.02	-74.88	-33.67	195.33	45.46
Dividend Per Share, 2 Yr. CAGR %	58.11	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	17.11	10.78	6.41	0.2	3.17
Gross Profit, 3 Yr. CAGR %	20.24	7.56	0.37	-3.24	6.08
EBITDA, 3 Yr. CAGR %	33.92	-8.72	-42.75	-28.4	17.19
EBITA, 3 Yr. CAGR %	42.09	-14.55	-62.59	-43.27	21.53
EBIT, 3 Yr. CAGR %	54.5	-13.66	-50.33	-48.34	20.23
Earnings From Cont. Operations, 3 Yr. CAGR %	117.24	-7.47	14.13	-34.31	-10.35
Net Income, 3 Yr. CAGR %	-39.05	-5.36	20.12	-27.84	-18.86
Normalized Net Income, 3 Yr. CAGR %	155.03	2.82	-8.58	-30.02	-20.02
Diluted EPS Before Extra, 3 Yr. CAGR %	365.64	-6.05	19.64	-27.91	-19.51
Accounts Receivable, 3 Yr. CAGR %	10.24	5.77	2.27	-1.02	3.32
Inventory, 3 Yr. CAGR %	18.57	20.25	16.41	9.41	3.46
Net Property, Plant and Equip., 3 Yr. CAGR %	15.3	10.03	-0.36	-3.64	-2.82
Total Assets, 3 Yr. CAGR %	1.22	1.27	1.49	3.42	3.35
Tangible Book Value, 3 Yr. CAGR %	10.19	1.6	-4.85	-10.91	-3.11
Common Equity, 3 Yr. CAGR %	3.96	-0.68	0.56	-3.37	0.59
Cash From Operations, 3 Yr. CAGR %	36.38	-35.87	-47.38	-35.64	39.67
Capital Expenditures, 3 Yr. CAGR %	3.96	8.46	28.39	-16.45	6.38
Levered Free Cash Flow, 3 Yr. CAGR %	28.05	-49.88	6.5	-18.51	347.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	70.03	-56.44	-17.35	-7.09	116.34
Dividend Per Share, 3 Yr. CAGR %	35.72	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	17.57	15.63	10.88	5.68	5.64
Gross Profit, 5 Yr. CAGR %	17.9	13.94	8.69	3.99	5.1
EBITDA, 5 Yr. CAGR %	27.68	11.14	-18.59	-9.98	-0.96
EBITA, 5 Yr. CAGR %	61.58	14.77	-35.13	-20.24	-3.83
EBIT, 5 Yr. CAGR %	60.33	26.31	-19.63	-23.83	-4.26
Earnings From Cont. Operations, 5 Yr. CAGR %	42.2	26.58	64.3	-12.24	-17.03
Net Income, 5 Yr. CAGR %	38.89	24.44	-22.07	-5.92	-20.73
Normalized Net Income, 5 Yr. CAGR %	47.29	36	48.37	0.7	-20.31
Diluted EPS Before Extra, 5 Yr. CAGR %	31.98	28.43	163.89	-6.23	-21.49
Accounts Receivable, 5 Yr. CAGR %	12.46	5.27	5.71	3.82	2.64
Inventory, 5 Yr. CAGR %	14.37	16.69	16.89	11.59	11.92
Net Property, Plant and Equip., 5 Yr. CAGR %	-4.12	-4.1	9.19	4.97	-3.4
Total Assets, 5 Yr. CAGR %	-1.84	-5.42	2.63	2.11	1.84
Tangible Book Value, 5 Yr. CAGR %	-7.82	-7.36	0.51	-3.5	-2.35
Common Equity, 5 Yr. CAGR %	-5.11	-6.65	1.53	-1.46	0.5
Cash From Operations, 5 Yr. CAGR %	362.89	33.59	-17.96	-23.4	-6.29
Capital Expenditures, 5 Yr. CAGR %	-4.22	-16.24	12.88	3.9	-0.82
Levered Free Cash Flow, 5 Yr. CAGR %	-12.12	-34.48	9.32	3.8	-0.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	-6.68	-25.2	16.2	6.16	3.62